title: Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation.
abstract: Ligation of CD40 on dendritic cells (DCs) induces early production of inflammatory mediators via canonical NF-kappaB signaling, as well as late expression of the anti-inflammatory enzyme indoleamine 2,3-dioxygenase (IDO) via unknown signal transduction. By selective blocking of either the canonical NF-kappaB pathway using the NEMO-binding domain peptide or the noncanonical NF-kappaB pathway by small interfering RNA, we demonstrate that IDO expression requires noncanonical NF-kappaB signaling. Also, noncanonical NF-kappaB signaling down-regulates proinflammatory cytokine production in DCs. In addition, selective activation of the noncanonical NF-kappaB pathway results in noninflammatory DCs that suppress T-cell activation and promote the development of T cells with regulatory properties. These findings reveal an important role of the noncanonical NF-kappaB pathway in the regulation of immunity.
authors.affiliation: Division of Clinical Immunology and Rheumatology, Academic Medical Center (AMC)/University of Amsterdam, Amsterdam, the Netherlands.
authors.forename: Sander W
authors.initials: SW
authors.lastname: Tas
authors.forename: Margriet J
authors.initials: MJ
authors.lastname: Vervoordeldonk
authors.forename: Najat
authors.initials: N
authors.lastname: Hajji
authors.forename: Joost H N
authors.initials: JH
authors.lastname: Schuitemaker
authors.forename: Koen F
authors.initials: KF
authors.lastname: van der Sluijs
authors.forename: Michael J
authors.initials: MJ
authors.lastname: May
authors.forename: Sankar
authors.initials: S
authors.lastname: Ghosh
authors.forename: Martien L
authors.initials: ML
authors.lastname: Kapsenberg
authors.forename: Paul P
authors.initials: PP
authors.lastname: Tak
authors.forename: Esther C
authors.initials: EC
authors.lastname: de Jong
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis / Q000276:immunology; D003713:Dendritic Cells / Q000201:enzymology / Q000276:immunology*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D051550:I-kappa B Kinase / Q000276:immunology / Q000378:metabolism; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000096:biosynthesis / Q000276:immunology*; D007249:Inflammation / Q000276:immunology / Q000378:metabolism; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000378:metabolism; D010455:Peptides / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects / Q000276:immunology; D034741:RNA, Small Interfering / Q000276:immunology / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism
chemical_list: D016207:Cytokines; C491731:IKBKG protein, human; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D016328:NF-kappa B; D010455:Peptides; D034741:RNA, Small Interfering; D051550:I-kappa B Kinase